Locus 67: ADRA1A (8p21.2)
| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs13278849 |
levulinate (4-oxovalerate) |
A/G |
6535 |
0.73 |
-0.013 (0.002) |
2.79·10-11 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs13278849 |
| Chromosomal location | Chr8: 26,770,791 (8p21.2) |
| Gene (distance) | ADRA1A (0) |
| Predicted causal gene | unknown |
| Gene/protein classification | drug target |
| Metabolite (Pathway) | levulinate (4-oxovalerate) (Valine, leucine and isoleucine metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | - |
| eQTL associations | - |
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL229 |
| Drug information |
Dopamine, Doxazosin, Epinephrine, Labetalol, Metaraminol, Methoxamine, Midodrine, Norepinephrine, Phenoxybenzamine, Phentolamine, Phenylpropanolamine, Prazosin, Pseudoephedrine, Tolazoline, Dapripazole, Dipivrefin, Naphazoline, Oxymetazoline, Phenylephrine, Tetrahydrozoline, among others
(more details...) |
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

